Receptos Inc (NASDAQ:RCPT) said the Phase 2 portion of the RADIANCE trial of its selective S1P1 receptor modulator, RPC1063, in relapsing…
Allergan (AGN) is higher in Friday’s after-hours session after disclosing that Valeant Pharmaceuticals International and Pershing Square Capital Management made…
Following what has been a tough stretch for the GenMark Diagnostics, we hosted the company’s CEO Hany Massarany for meetings with…
On Wednesday, BioDelivery Sciences received a positive court ruling when the judge presiding over the case between Reckitt Benckiser and…
Zoetis reported first-quarter non-GAAP EPS on Tuesday, that exceeded our expectations by $0.02 and consensus by $0.01. Commentary suggested there…
Last week, Vocera Communications reported relatively solid first quarter 2014 results, with a number of highlights: The company topped both…